Jonathan Steif

Jonathan Steif

Auto-generated profile, based on publicly available information

Jonathan Steif

Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
EKElizabeth King
Elizabeth King
KKKaren Kinvig
Karen Kinvig
JSJonathan Steif
Jonathan Steif
AQAnnie Q Qiu
Annie Q Qiu
EMEvelyn J Maan
Evelyn J Maan
Melanie MurrayMelanie Murray
Melanie Murray
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

20 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
AHAxel Hauduc
Axel Hauduc
JSJonathan Steif
Jonathan Steif
MBMisha Bilenky
Misha Bilenky
MMMichelle Moksa
Michelle Moksa
QCQi Cao
Qi Cao
MHMartin Hirst
Martin Hirst
Background: Understanding the interplay between genomic variation and the epigenome is fundamental to the study of development and mechanisms of disease. Previous studies have leveraged population-scale genotype surveys to associate alleles with epigenomic states in heterogenous tissue types. However, epigenomes are inherently cell type-specific, giving rise to unique genome-epigenome interactions that can influence distinct functional states and susceptibility to disease. Moreover, the extent of individual variation in cell type-specific epigenotypes remains poorly understood, posing additional challenges to accurately link genotypes with epigenomic features. Results: We generated comprehensive genomic and epigenomic profiles of four functionally defined human breast epithelial cell types from eight healthy individuals. To quantify inter-individual epigenomic variation, we developed a statistical framework that measures variability in histone modification landscapes across individuals. This analysis revealed substantially greater variation in repressive chromatin marked by H3K27me3 than in active chromatin marked by H3K27ac and H3K4me3. Integrative chromatin state analysis further identified enhancer elements as the principal source of epigenomic divergence between individuals. Stable enhancer states corresponded to high-confidence cis -regulatory elements that underpin cell type-specific transcriptional programs, whereas variable enhancer states were enriched for environmentally responsive regulatory circuits. Mapping genetic variants associated with chromatin state variation uncovered extensive cell type specificity, with nearly 90% of regulatory variants detected in only a single cell type. These associations were strongly enriched within active regulatory chromatin and, when integrated with gene expression, enabled the prioritization of functional regulatory variants. We experimentally validated one such variant, rs75071948, demonstrating allele-specific regulation of ANXA1 expression using CRISPR/Cas9 genome editing. Conclusions: Our study defines the landscape of normal epigenomic variation across the major human breast epithelial cell types and demonstrates that genome-epigenome interactions are highly cell type-specific. These findings establish cell type as a critical determinant of the functional interpretation of regulatory genetic variation and provide a framework for understanding how inherited genetic variation shapes normal breast biology and disease susceptibility.